PT1254120E - Uso de antagonistas de endotelina de pirimidina em animais de companhia - Google Patents

Uso de antagonistas de endotelina de pirimidina em animais de companhia

Info

Publication number
PT1254120E
PT1254120E PT01902578T PT01902578T PT1254120E PT 1254120 E PT1254120 E PT 1254120E PT 01902578 T PT01902578 T PT 01902578T PT 01902578 T PT01902578 T PT 01902578T PT 1254120 E PT1254120 E PT 1254120E
Authority
PT
Portugal
Prior art keywords
pyrimidine
animals
endotheline antagonists
company
endotheline
Prior art date
Application number
PT01902578T
Other languages
English (en)
Inventor
Stephen P Gibson
Bernard J Banks
Adrian P Foster
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Publication of PT1254120E publication Critical patent/PT1254120E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
PT01902578T 2000-02-11 2001-02-06 Uso de antagonistas de endotelina de pirimidina em animais de companhia PT1254120E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment

Publications (1)

Publication Number Publication Date
PT1254120E true PT1254120E (pt) 2004-10-29

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01902578T PT1254120E (pt) 2000-02-11 2001-02-06 Uso de antagonistas de endotelina de pirimidina em animais de companhia

Country Status (17)

Country Link
EP (1) EP1254120B1 (pt)
JP (1) JP2003528050A (pt)
KR (1) KR20020075791A (pt)
AT (1) ATE271042T1 (pt)
AU (1) AU3043601A (pt)
CA (1) CA2398007A1 (pt)
DE (1) DE60104283T2 (pt)
DK (1) DK1254120T3 (pt)
ES (1) ES2222975T3 (pt)
GB (1) GB0003234D0 (pt)
HU (1) HUP0204370A3 (pt)
IL (1) IL150488A0 (pt)
NZ (1) NZ519002A (pt)
PT (1) PT1254120E (pt)
TR (1) TR200401815T4 (pt)
WO (1) WO2001058882A1 (pt)
ZA (1) ZA200206343B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
RU2376035C2 (ru) * 2005-04-19 2009-12-20 Хилл`С Пет Ньютришн, Инк. Способы и композиции для предотвращения и лечения болезни почек у кошек
US8778617B2 (en) * 2010-02-25 2014-07-15 Hoffmann-La Roche Inc. Method for determining the binding constant of high affinity compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882719B1 (en) * 1995-12-20 2001-05-16 Yamanouchi Pharmaceutical Co. Ltd. Arylethenesulfonamide derivatives and drug composition containing the same
WO1998057938A1 (fr) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Derives d'alcanesulfonamide inferieur substitue et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
NZ519002A (en) 2004-06-25
AU3043601A (en) 2001-08-20
DE60104283D1 (de) 2004-08-19
HUP0204370A2 (en) 2003-05-28
ZA200206343B (en) 2003-08-08
DE60104283T2 (de) 2004-11-18
JP2003528050A (ja) 2003-09-24
IL150488A0 (en) 2002-12-01
KR20020075791A (ko) 2002-10-05
ATE271042T1 (de) 2004-07-15
CA2398007A1 (en) 2001-08-16
TR200401815T4 (tr) 2004-08-23
EP1254120B1 (en) 2004-07-14
ES2222975T3 (es) 2005-02-16
GB0003234D0 (en) 2000-04-05
WO2001058882A1 (en) 2001-08-16
EP1254120A1 (en) 2002-11-06
DK1254120T3 (da) 2004-10-04
HUP0204370A3 (en) 2003-07-28

Similar Documents

Publication Publication Date Title
DK1257175T3 (da) Brug af syrestabile Subtilisin Proteaser i dyrefoder.
TR200102839T2 (tr) LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler.
ID28812A (id) Enzima-enzima antimikroba di dalam pakan hewan
BR0107246A (pt) Agentes diazabicìclicos ativos no sistema nervoso central
NL300149I1 (nl) Samenstelling met insecticide werking tegen vlooien bij zoogdieren, in het bijzonder honden en katten.
ITMO910147A0 (it) Tavolo per asciugatura e toellettatura cani, gatti e altri animali domestici.
BR0010355A (pt) Uso de creatina como aditivo de ração
DK1331855T3 (da) Husdyrdiætfoder til ældre dyr
RS51054B (sr) Upotreba antagonista neuronskih natrijumovih kanala za kontrolu ektoparazita kod toplokrvnih životinja
BR0010189A (pt) Suplemento de ácido fólico
EE200300101A (et) Bensofenantridiinalkaloidi kasutamine söödalisandina ja loomasööt
PT1254120E (pt) Uso de antagonistas de endotelina de pirimidina em animais de companhia
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
MXPA03008681A (es) (oxo-pirazol[1,5]pirimidin-2-il)alquil-carboxamidas.
BR0011330A (pt) 2-aril-1,2,4-triazina-3,5-di(ti)onas substituìdas
AU2000251168A1 (en) Feed additives, forage and agents for animals, methods for the use thereof
ES1050329Y (es) Comedero para ganado perfeccionado.
ES1051402Y (es) Recogedor de excrementos de animales.
ES1049486Y (es) Recogedor de excremntos animales perfeccionado.
ES1042120Y (es) Dispositivo para la recogida de excrementos de aninales y similares.
BG101048A (en) Shampoo
Beatley The Science of Conservation Planning: Habitat Conservation under the Endangered Species Act
RU99116483A (ru) Вещество, обладающее психостимулирующим и антиастеническим действием
RU2001105594A (ru) Кормовая добавка
ES1046215Y (es) Recogedor de excrementos de animales.